Back to Newsroom

Cyclacel Pharmaceuticals to Release Second Quarter 2017 Financial Results

BERKELEY HEIGHTS, N.J., Aug. 02, 2017 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce second quarter 2017 financial results on Wednesday, August 9, 2017. The Company will host a conference call and live webcast at 4:30 p.m. ET on the same day.
READ MORE…